This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The goal of this study is to test the utility of a novel biomarker (the """"""""Interferon Signature"""""""") for predicting onset of clinical autoimmunity (including lupus).
Showing the most recent 10 out of 724 publications